Invasive hepatic mucormycosis: A case report and review of the literature.
Aged
Amphotericin B
/ administration & dosage
Antifungal Agents
/ administration & dosage
Autopsy
Fatal Outcome
Ferritins
/ blood
Galactose
/ analogs & derivatives
Humans
Invasive Fungal Infections
/ blood
Liver Diseases
/ diagnosis
Male
Mannans
/ blood
Mucormycosis
/ blood
Primary Myelofibrosis
/ blood
Spleen
/ pathology
Hepatic mucormycosis
Liver
Myelofibrosis
Solid organ transplantation
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
04
12
2017
revised:
21
06
2018
accepted:
25
06
2018
pubmed:
31
7
2018
medline:
9
5
2019
entrez:
31
7
2018
Statut:
ppublish
Résumé
Mucormycosis generally develops under immunocompromised conditions, including hematological malignancies and solid organ or hematopoietic stem cell transplantation. Although mucormycosis usually affects the lungs and paranasal sinuses, sporadic cases of invasive mucormycosis of the liver have been reported. We hereby report a patient with myelofibrosis who developed hepatic mucormycosis diagnosed by post-mortem examination. An extensive literature review identified 13 reported cases of hepatic mucormycosis, including ours, without lung involvement. Most of the underlying diseases or conditions were hematological malignancies and solid organ transplantation. Three cases had splenic lesions and four had gastrointestinal lesions, suggesting the possibility of translocation to the liver and/or spleen from the gastrointestinal tracts. Hepatic mucormycosis should be recognized as one of the presentations of invasive mucormycosis, especially when hepatic nodules are found in immunocompromised patients such as those with hematological malignancy or recipients of solid organ transplantation.
Identifiants
pubmed: 30057341
pii: S1341-321X(18)30186-7
doi: 10.1016/j.jiac.2018.06.013
pii:
doi:
Substances chimiques
Antifungal Agents
0
Mannans
0
galactomannan
11078-30-1
Amphotericin B
7XU7A7DROE
Ferritins
9007-73-2
Galactose
X2RN3Q8DNE
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-53Informations de copyright
Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.